ADIPOQ and hypertensive disorder: Diabetes (p = 0.916), cardiovascular disease (p = 0.781), and hypertension (p = 0.297) in the moderate COVID-19 group, and diabetes in the severe cohort (p = 0.598), were not associated with a change in serum adiponectin levels.